Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.12 -0.01 (-0.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Sales of Property, Plant and Equipment (2023)

Updated

Adial Pharmaceuticals' Sales of Property, Plant and Equipment came in at $350,000 for Q4 2023, unchanged from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Sales of Property, Plant and Equipment (2023) Analysis & Trends

For FY2023, Adial Pharmaceuticals' Sales of Property, Plant and Equipment was $1.5 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Adial Pharmaceuticals 19.04 Mn 19.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 350,000.00
Sep 30, 2023 350,000.00
API Access

Adial Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=ADIL&period=max&api_key=YOUR_API_KEY